X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1864) 1864
Publication (286) 286
Book Review (21) 21
Book Chapter (5) 5
Newsletter (5) 5
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1397) 1397
index medicus (1119) 1119
immunology (974) 974
neisseria meningitidis (708) 708
vaccines (668) 668
meningitis (654) 654
neisseria-meningitidis (625) 625
infectious diseases (570) 570
meningococcal vaccines - immunology (545) 545
neisseria meningitidis - immunology (541) 541
female (507) 507
microbiology (492) 492
adolescent (452) 452
male (452) 452
child (401) 401
meningococcal infections - prevention & control (398) 398
meningococcal disease (394) 394
vaccination (393) 393
disease (382) 382
animals (380) 380
adult (379) 379
infant (357) 357
child, preschool (348) 348
proteins (347) 347
epidemiology (343) 343
immunogenicity (331) 331
immunization (329) 329
meningococcal vaccines - administration & dosage (320) 320
medicine, research & experimental (297) 297
meningococcal infections - epidemiology (288) 288
bacteria (268) 268
medicine (266) 266
neisseria meningitidis - genetics (265) 265
vaccine (262) 262
antibodies, bacterial - blood (259) 259
antigens (256) 256
meningococcal infections - microbiology (243) 243
meningococcal infections - immunology (237) 237
research (233) 233
meningitis, meningococcal - prevention & control (232) 232
mice (232) 232
research article (232) 232
neisseria meningitidis - classification (231) 231
young adult (224) 224
antigens, bacterial - immunology (212) 212
children (211) 211
meningitis, meningococcal - epidemiology (199) 199
neisseria meningitidis, serogroup b - immunology (197) 197
allergy and immunology (196) 196
serogroup (190) 190
epidemics (187) 187
antibodies (186) 186
health aspects (184) 184
middle aged (183) 183
conjugate vaccine (182) 182
neisseria meningitidis - isolation & purification (182) 182
vaccines, conjugate - immunology (182) 182
serotyping (180) 180
multidisciplinary sciences (174) 174
public health (170) 170
analysis (169) 169
prevention (165) 165
meningitis, meningococcal - immunology (160) 160
polysaccharides (160) 160
science (158) 158
identification (150) 150
meningitis, meningococcal - microbiology (146) 146
infections (145) 145
carriage (139) 139
biotechnology & applied microbiology (137) 137
meningococcal vaccines (137) 137
incidence (135) 135
meningococcal infections (134) 134
immune response (128) 128
meningococcal vaccines - adverse effects (128) 128
biology (127) 127
bacterial proteins - genetics (125) 125
antibodies, bacterial - immunology (122) 122
blood bactericidal activity (122) 122
safety (121) 121
surveillance (119) 119
antigens, bacterial - genetics (118) 118
united-states (116) 116
molecular sequence data (115) 115
invasive meningococcal disease (114) 114
aged (113) 113
neisseria meningitidis - pathogenicity (113) 113
immunity (112) 112
bacterial outer membrane proteins - immunology (110) 110
bactericidal activity (109) 109
polysaccharides, bacterial - immunology (109) 109
teenagers (108) 108
age (107) 107
enzyme-linked immunosorbent assay (107) 107
escherichia-coli (107) 107
infants (106) 106
laboratories (106) 106
bacterial proteins - immunology (105) 105
serogroup-b (104) 104
disease outbreaks (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1839) 1839
French (14) 14
Spanish (9) 9
Russian (4) 4
Japanese (2) 2
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Immunology, ISSN 0022-1767, 07/2010, Volume 185, Issue 1, pp. 507 - 516
Properdin, a positive regulator of the alternative pathway (AP) of complement is important in innate immune defenses against invasive Neisserial infections.... 
C4B-BINDING PROTEIN | MOLECULAR-MECHANISM | SERUM RESISTANCE | FACTOR-H BINDING | COMPLEMENT DEFICIENCY STATES | SEROGROUP-B | HEREDITARY PROPERDIN | REGULATORY PROTEIN | FULMINANT MENINGOCOCCAL INFECTIONS | IMMUNOLOGY | CAPSULE NULL LOCUS | Neisseria meningitidis, Serogroup A - immunology | Neisseria meningitidis, Serogroup C - immunology | Humans | Neisseria meningitidis, Serogroup B - immunology | Neisseria meningitidis, Serogroup Y - genetics | Neisseria meningitidis, Serogroup B - genetics | Neisseria meningitidis, Serogroup B - metabolism | Neisseria meningitidis, Serogroup W-135 - metabolism | Neisseria meningitidis, Serogroup C - metabolism | Neisseria meningitidis, Serogroup A - metabolism | Neisseria meningitidis, Serogroup A - genetics | Neisseria gonorrhoeae - immunology | Complement Pathway, Alternative - genetics | Neisseria gonorrhoeae - genetics | Neisseria meningitidis, Serogroup C - genetics | Neisseria meningitidis, Serogroup W-135 - genetics | Bacterial Adhesion - immunology | Complement C3 - metabolism | Complement C3 Convertase, Alternative Pathway - metabolism | Properdin - physiology | Protein Binding - immunology | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup Y - metabolism | Neisseria meningitidis, Serogroup W-135 - immunology | Complement Pathway, Alternative - immunology | Enzyme Stability - immunology | Neisseria gonorrhoeae - metabolism | Properdin - isolation & purification | Properdin - metabolism
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 04/2015, Volume 17, Issue 2, pp. 322 - 327
Immunization against meningococcal disease is recommended for solid organ transplant (SOT) recipients at high risk for meningococcal disease or travelling to... 
meningococcal vaccine | solid organ transplantation | Neisseria meningitidis | antibody response | immunization | Immunization | Solid organ transplantation | Antibody response | Meningococcal vaccine | IMMUNE-RESPONSE | INFECTIOUS DISEASES | CONJUGATE VACCINE | SAFETY | IMMUNOLOGY | CHILDREN | TRANSPLANTATION | RECOMMENDATIONS | REVACCINATION | ADOLESCENTS | DISEASE | C VACCINE | POLYSACCHARIDE | Immunocompromised Host - immunology | Neisseria meningitidis, Serogroup A - immunology | Liver Transplantation | Meningococcal Vaccines - therapeutic use | Neisseria meningitidis, Serogroup C - immunology | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Transplant Recipients | Neisseria meningitidis - immunology | Vaccines, Conjugate - immunology | Adult | Female | Graft Rejection - prevention & control | Meningococcal Infections - prevention & control | Kidney Transplantation | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup W-135 - immunology | Vaccines, Conjugate - therapeutic use | Antibodies, Bacterial - immunology | Aged | Meningococcal Vaccines - immunology | Cohort Studies | Transplantation of organs, tissues, etc | Organ transplant recipients | Meningitis | Vaccines | Immunosuppressive Agents | Antibodies, Bacterial | Life Sciences | Immunology | Neisseria meningitidis, Serogroup C | Vaccines, Conjugate | Neisseria meningitidis, Serogroup A | Meningococcal Vaccines | Neisseria meningitidis, Serogroup W-135 | Vaccinology | Neisseria meningitidis, Serogroup Y | Graft Rejection | Immunocompromised Host | Meningococcal Infections
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 10/2016, Volume 22, Issue 10, pp. 1762 - 1768
In 2015, Niger reported the largest epidemic of Neisseria meningitidis serogroup C (NmC) meningitis in sub-Saharan Africa. The NmC epidemic coincided with... 
AFRICA | INFECTIOUS DISEASES | CARRIAGE | BURKINA-FASO | W135 | MENINGOCOCCAL MENINGITIS | H BINDING-PROTEIN | DISEASE | VACCINE | SUSCEPTIBILITY | DIVERSITY | IMMUNOLOGY | Communicable Diseases, Emerging | Epidemics | Genome, Bacterial | Neisseria meningitidis, Serogroup C - genetics | Niger - epidemiology | Humans | Phylogeny | Antigens, Bacterial - genetics | Neisseria meningitidis - isolation & purification | Sequence Analysis, DNA | Meningitis, Meningococcal - epidemiology | Molecular Typing | DNA, Bacterial | Genetic Variation | Meningitis, Meningococcal - microbiology | Neisseria meningitidis - genetics | Drug Resistance, Bacterial - genetics | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | Neisseria meningitidis/genetics | Neisseria meningitidis, Serogroup C/genetics | Life Sciences | Neisseria meningitidis/isolation & purification | Genetics | Antigens, Bacterial/genetics | Meningitis, Meningococcal/epidemiology | Meningitis, Meningococcal/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Niger/epidemiology | Neisseria meningitidis, Serogroup C/isolation & purification | Drug Resistance, Bacterial/genetics | Santé publique et épidémiologie | Neisseria meningitidis serogroup C | meningitis belt | bacteria | Niger | whole-genome sequencing | Research | Serogroup C and Resurging Serogroup W, Niger, 2015 | Whole-Genome Characterization of Epidemic | Meningococcal meningitis
Journal Article
PLoS Medicine, ISSN 1549-1277, 2006, Volume 3, Issue 9, pp. 1579 - 1586
Background Outbreaks of meningococcal meningitis ( meningitis caused by Neisseria meningitidis) are a major public health concern in the African "meningitis... 
AFRICA | MEDICINE, GENERAL & INTERNAL | ASSAY | NIGER | W135 | MENINGOCOCCAL MENINGITIS | SEQUENCE | IDENTIFICATION | CONFIDENCE | PCR | Neisseria meningitidis, Serogroup A - immunology | Predictive Value of Tests | Africa - epidemiology | Neisseria meningitidis, Serogroup C - immunology | Neisseria meningitidis, Serogroup W-135 - isolation & purification | Neisseria meningitidis, Serogroup Y - isolation & purification | Prospective Studies | Meningitis, Meningococcal - diagnosis | Humans | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - immunology | Polymerase Chain Reaction - methods | Likelihood Functions | Time Factors | Sensitivity and Specificity | Neisseria meningitidis, Serogroup C - isolation & purification | Serotyping | Reproducibility of Results | Chromatography - methods | Antibodies, Monoclonal | Neisseria meningitidis, Serogroup Y - immunology | Neisseria meningitidis, Serogroup A - isolation & purification | Neisseria meningitidis, Serogroup W-135 - immunology | Reagent Kits, Diagnostic | Meningitis, Meningococcal - cerebrospinal fluid | Evaluation Studies as Topic | Causes of | Medical tests | Neisseria meningitidis | Diagnosis | Health aspects | Bioengineering | Neisseria menin | Africa | Chromatography | Meningitis, Meningococcal | Neisseria meningitidis, Serogroup W-135 | Life Sciences | Human health and pathology | Infectious diseases | Immunology | Neisseria meningitidis, Serogroup C | Santé publique et épidémiologie | Neisseria meningitidis, Serogroup A | Evaluation Studies | Biotechnology | Public Health | Microbiology | Medicine in Developing Countries | Infectious Diseases | Vaccines | Primary Care | Epidemiology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 3, pp. 275 - 278
Journal Article
Journal Article
JOURNAL OF INFECTIOUS DISEASES, ISSN 0022-1899, 12/2019, Volume 220, Issue 220 Suppl 4, pp. S216 - S224
Background. During 2014, 4 regions in Togo within the African meningitis belt implemented vaccination campaigns with meningococcal serogroup A conjugate... 
INFECTIOUS DISEASES | Togo | BURKINA-FASO | W135 | NIGER | MENINGOCOCCAL MENINGITIS | epidemic | MICROBIOLOGY | Neisseria meningitidis | IMMUNOLOGY | IDENTIFICATION | vaccination | Supplement
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2006, Volume 103, Issue 29, pp. 10834 - 10839
Journal Article
Journal of Infection, ISSN 0163-4453, 2017, Volume 75, Issue 2, pp. 95 - 103
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 31, Issue 7, pp. 1113 - 1116
Journal Article